Skip to main content
BRZE
NASDAQ Technology

Braze Reports Strong Q1 FY27 Results, Executes $50M Share Repurchase, but Discloses Persistent Material Weakness

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$22.59
Mkt Cap
$2.748B
52W Low
$15.26
52W High
$37.67
Market data snapshot near publication time

Summary

Braze, Inc. reported strong first-quarter fiscal year 2027 financial results with 30.2% revenue growth and improved net loss, alongside the execution of a $50 million share repurchase. However, the company continues to report a material weakness in its internal controls over financial reporting.


Key Events

  • Strong Q1 FY27 Financial Performance

    Revenue increased 30.2% year-over-year to $211.0 million, and net loss improved to $25.5 million from $35.6 million in the prior year. Operating cash flow was $28.1 million.

  • Persistent Material Weakness in Internal Controls

    The company continues to report a material weakness in its information technology general controls (ITGCs) as of April 30, 2026, impacting user access and program change management. Remediation efforts are ongoing.

  • $50 Million Share Repurchase Executed

    Braze repurchased 1,716,002 shares of Class A common stock for $50.0 million through an accelerated share repurchase (ASR) transaction, part of a larger $100 million authorized program.

  • Executive 10b5-1 Plans Established/Modified

    CTO Jon Hyman modified a plan to sell up to 712,000 shares and 94,388 RSUs, while CRO Edward McDonnell entered a new plan to sell 47,355 RSUs.


Analysis

This quarterly report confirms Braze's strong Q1 FY27 financial performance, with robust revenue growth and improved profitability, demonstrating continued business momentum. The execution of a $50 million share repurchase program signals management's confidence and commitment to shareholder returns. However, the persistent disclosure of a material weakness in internal controls over financial reporting is a significant concern, indicating ongoing deficiencies in financial reporting processes. While remediation is underway, this issue can impact investor confidence and the reliability of financial statements. Additionally, new 10b5-1 selling plans from the CTO and CRO, though pre-planned, represent future selling pressure from key executives. The CFO's signing of this report just before her departure adds to the context of executive changes during this period.

At the time of this filing, BRZE was trading at $22.59 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $15.26 to $37.67. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BRZE - Latest Insights

BRZE
May 27, 2026, 5:47 PM EDT
Filing Type: 10-Q
Importance Score:
7
BRZE
May 27, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
BRZE
May 27, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
BRZE
May 18, 2026, 4:31 PM EDT
Filing Type: DEFA14A
Importance Score:
7
BRZE
May 18, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
BRZE
May 08, 2026, 4:32 PM EDT
Filing Type: PRE 14A
Importance Score:
8
BRZE
Mar 24, 2026, 5:52 PM EDT
Filing Type: 10-K
Importance Score:
8
BRZE
Mar 24, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
BRZE
Feb 02, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7